BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.)

Issues related to drug pricing, including federal proposals impacting reimbursement, access, and affordability; Issues related to Medicare Drug negotiation and implementation of the Inflation Reduction Act; Pharmacy benefit manager reform legislation; Issues related to Most Favored Nation (MFN) pricing models

Engaged with the Securities and Exchange Commission on a regulatory matter